Maastricht Radiation Oncology
maastro.nlTotal trials
106
Active
18
Phase 3
3
Total enrollment
69,246
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Breast Cancer9
- Lung Cancer9
- Non-small Cell Lung Cancer7
- Non Small Cell Lung Cancer6
- Glioblastoma5
- NSCLC5
- Rectal Cancer5
- Prostate Cancer4
Frequently asked questions about Maastricht Radiation Oncology
- How many clinical trials does Maastricht Radiation Oncology have on ClinicalTrials.gov?
- Maastricht Radiation Oncology is listed as the lead sponsor on 106 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Maastricht Radiation Oncology's trials are in Phase 3?
- 3 of Maastricht Radiation Oncology's trials are in Phase 3.
- What therapeutic areas does Maastricht Radiation Oncology focus on?
- Maastricht Radiation Oncology's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Lung Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Glioblastoma.